Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.
Through Takeda’s partnership with Shot@Life, they are helping to expand access to lifesaving measles vaccines to children in approximately 40 countries in Africa, Asia and Latin America, many living in hard-to-reach locations. Takeda’s support will help vaccinate millions of children by 2026.